FRANCIS LAURA sold $762K of SIBN (indirect holdings)
FRANCIS LAURA (Chief Executive Officer) sold 38,006 indirectly-held shares of SI-BONE, Inc. (SIBN) at $20.05 ($0.76M total) on 2026-10-12 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
While the sale reduces the CEO's holdings, the amount is modest relative to the company's market cap, suggesting limited price impact.
Market read
The filing provides a fresh, primary source of insider activity that may slightly affect short‑term sentiment for SIBN.
What to watch
Potential upcoming corporate actions or financing needs not disclosed in the filing.
Background
Form 4 filings disclose insider transactions and are used by traders to gauge insider sentiment.
Ticker impact
CEO Laura Francis sold 38,006 shares for $762K via a 10b5-1 plan, reducing her stake to 379,256 shares.
likely modest pressure as the market prices in the insider sell
A $762K sale by the chief executive is material but modest in size; investors often view such sales as a mild negative signal.
Market effects
Minimal impact on the orthopedics device sector; no broader industry trend indicated.
Limited to U.S. investors tracking insider activity.
Low; the filing is company‑specific.
Counterpoint
The sale could be a routine liquidity event unrelated to fundamentals, so the stock may remain stable.
Key entities
- ExecutiveLaura Francis
Chief Executive Officer of SI‑BONE, Inc.
